Interleukin (IL)‐17‐producing pathogenic T lymphocytes co‐express CD20 and are depleted by rituximab in primary Sjögren's syndrome: a pilot study
2016 ◽
Vol 184
(3)
◽
pp. 284-292
◽
2001 ◽
2013 ◽
Vol 72
(Suppl 3)
◽
pp. A274.1-A274
◽
2015 ◽
Vol 74
(Suppl 2)
◽
pp. 339.1-339